Literature DB >> 18821492

Fatality in a case of envenomation by Crotalus adamanteus initially successfully treated with polyvalent ovine antivenom followed by recurrence of defibrinogenation syndrome.

Craig Kitchens1, Thomas Eskin.   

Abstract

INTRODUCTION: Recurrences of clinical or laboratory manifestations of North American pit viper envenomation may happen despite control of the envenomation syndrome by prompt and adequate antivenom therapy. Recurrences of coagulopathy in victims of Eastern diamondback rattlesnake envenomation are generally regarded as benign. The vast majority suffer no actual bleeding despite florid coagulation laboratory abnormalities due to selective defibrinogenation. CASE REPORT: We report what we believe to be the first fatality following successful control of the envenomation syndrome following ovine antivenom treatment resulting from envenomation by a bite from the Eastern diamondback rattlesnake. This case raises the question of whether such recurrences are in fact benign, causal, or coincidental. This patient sustained significant brain hemorrhage and death ensued due to generalized cerebral edema. Defibrinogenation occurred 4 days after treatment with ovine antivenom. DISCUSSION: Coagulation abnormalities following Eastern diamondback rattlesnake envenomation are due to selective defibrinogenation. This is separate from disseminated intravascular coagulation (DIC). Thrombin generation, thus hemostasis, are generally considered normal. This case may cause reexamination of this belief.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18821492      PMCID: PMC3550043          DOI: 10.1007/bf03161198

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  11 in total

1.  From ETOH to FAB: the medicalization of therapy for pit viper envenomation.

Authors:  C S Kitchens
Journal:  Trans Am Clin Climatol Assoc       Date:  2001

Review 2.  Hemostatic aspects of envenomation by North American snakes.

Authors:  C S Kitchens
Journal:  Hematol Oncol Clin North Am       Date:  1992-10       Impact factor: 3.722

Review 3.  Bites of venomous snakes.

Authors:  Barry S Gold; Richard C Dart; Robert A Barish
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245

4.  To bleed or not to bleed? Is that the question for the PTT?

Authors:  C S Kitchens
Journal:  J Thromb Haemost       Date:  2005-09-09       Impact factor: 5.824

5.  Recurrent and persistent coagulopathy following pit viper envenomation.

Authors:  L V Boyer; S A Seifert; R F Clark; J T McNally; S R Williams; S P Nordt; F G Walter; R C Dart
Journal:  Arch Intern Med       Date:  1999-04-12

Review 6.  Snake venoms and coagulopathy.

Authors:  Julian White
Journal:  Toxicon       Date:  2005-04-12       Impact factor: 3.033

Review 7.  Poisonous snakebite: a review. 1. Snakes and their venom.

Authors:  L H Van Mierop
Journal:  J Fla Med Assoc       Date:  1976-03

8.  Recurrent coagulopathy after antivenom treatment of crotalid snakebite.

Authors:  G M Bogdan; R C Dart; S C Falbo; J McNally; D Spaite
Journal:  South Med J       Date:  2000-06       Impact factor: 0.954

9.  Mechanism of defibrination in humans after envenomation by the Eastern diamondback rattlesnake.

Authors:  C S Kitchens; L H Van Mierop
Journal:  Am J Hematol       Date:  1983-06       Impact factor: 10.047

10.  Validation of a severity score for the assessment of crotalid snakebite.

Authors:  R C Dart; K M Hurlbut; R Garcia; J Boren
Journal:  Ann Emerg Med       Date:  1996-03       Impact factor: 5.721

View more
  11 in total

Review 1.  Therapeutic potential of snake venom in cancer therapy: current perspectives.

Authors:  Vivek Kumar Vyas; Keyur Brahmbhatt; Hardik Bhatt; Utsav Parmar
Journal:  Asian Pac J Trop Biomed       Date:  2013-02

2.  Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop.

Authors:  Eric J Lavonas; Anne-Michelle Ruha; William Banner; Vikhyat Bebarta; Jeffrey N Bernstein; Sean P Bush; William P Kerns; William H Richardson; Steven A Seifert; David A Tanen; Steve C Curry; Richard C Dart
Journal:  BMC Emerg Med       Date:  2011-02-03

3.  Coagulopathy: the most important thing we still don't know about snakebite.

Authors:  Eric J Lavonas
Journal:  West J Emerg Med       Date:  2012-02

4.  Recurrent coagulopathy after rattlesnake bite requiring continuous intravenous dosing of antivenom.

Authors:  Charles W Hwang; F Eike Flach
Journal:  Case Rep Emerg Med       Date:  2015-01-12

5.  Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial.

Authors:  Sean P Bush; Anne-Michelle Ruha; Steven A Seifert; David L Morgan; Brandon J Lewis; Thomas C Arnold; Richard F Clark; William J Meggs; Eric A Toschlog; Stephen W Borron; Gary R Figge; Dawn R Sollee; Farshad M Shirazi; Robert Wolk; Ives de Chazal; Dan Quan; Walter García-Ubbelohde; Alejandro Alagón; Richard D Gerkin; Leslie V Boyer
Journal:  Clin Toxicol (Phila)       Date:  2014-10-31       Impact factor: 4.467

6.  Current treatment for venom-induced consumption coagulopathy resulting from snakebite.

Authors:  Kalana Maduwage; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

7.  Snake venom causes apoptosis by increasing the reactive oxygen species in colorectal and breast cancer cell lines.

Authors:  Abdulrahman Khazim Al-Asmari; Anvarbatcha Riyasdeen; Mohammad Hamed Al-Shahrani; Mozaffarul Islam
Journal:  Onco Targets Ther       Date:  2016-10-20       Impact factor: 4.147

Review 8.  Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19.

Authors:  Fatah Chérifi; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2021-09-09       Impact factor: 2.371

Review 9.  Crotaline Fab antivenom appears to be effective in cases of severe North American pit viper envenomation: an integrative review.

Authors:  Eric J Lavonas; Tammi H Schaeffer; Jamie Kokko; Sara L Mlynarchek; Gregory M Bogdan
Journal:  BMC Emerg Med       Date:  2009-06-22

10.  In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies.

Authors:  Andreas H Laustsen; Aneesh Karatt-Vellatt; Edward W Masters; Ana Silvia Arias; Urska Pus; Cecilie Knudsen; Saioa Oscoz; Peter Slavny; Daniel T Griffiths; Alice M Luther; Rachael A Leah; Majken Lindholm; Bruno Lomonte; José María Gutiérrez; John McCafferty
Journal:  Nat Commun       Date:  2018-10-02       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.